The Tisch Cancer Institute at Mount Sinai is a leader in translating clinical research into cancer immunotherapies for patients. PICI researcher Nina Bhardwaj, MD, PhD, at Mount Sinai is an expert who contributes foundational insights in understanding patient responses to immunotherapy treatments. She closely examines immune behavior to test and develop cancer-curing vaccines. Bhardwaj is instrumental on several PICI research projects and clinical trials, with a focus on prostate and pancreatic cancers. Nina Bhardwaj, MD, PhD | Investigator Related Research Focus Tumor Antigen Discovery: Targeting Cancer Research Project Tumor Neoantigen Selection Alliance (TESLA) Announcement, Press Release Funding the Future of Cancer Research Announcement, Press Release Alliance Aims to Develop Next-Gen Cancer Therapies Announcement, Press Release Biomarkers May Predict Better Treatment Options Announcement, Press Release First Patients Dosed in Pancreatic Platform Trial Partner Highlight Connecting Patients with Innovative Immunotherapies Our Impact, Partner Highlight All the Right Ingredients: The Founders of ArsenalBio Partner Highlight, Press Release NanoString and PICI Partner to Optimize Cell Therapies